Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day. The study finds that this so-called 'wonder drug' may be less ...
Dec 1, 2020
0
28
COVID-19 is caused by SARS-CoV-2, and has killed over 1,000,000 people around the world. It is impossible to create novel drugs against the coronavirus in a very short time, as drug development often takes years. Therefore, ...
Oct 26, 2020
0
6
The EU's medicines regulator on Friday gave the green light for the first injectable treatment for the HIV virus that causes AIDS, which could change the lives of millions of people.
Oct 16, 2020
0
25
Pulmonary hypertension is elevated blood pressure that occurs exclusively in the lungs. It is a deadly condition that affects an estimated 75 million people worldwide. Around 80% of them live in low- and middle-income countries. ...
Oct 9, 2020
0
1
In France, antiretroviral treatment (ARV) can be dispensed by hospitals and/or community pharmacies. A recent study published in Pharmacology Research & Perspectives examined the pharmacist's role in HIV care in this country.
Sep 10, 2020
0
1
With an increase in HIV and HCV infections as a consequence of the ongoing opioid epidemic, Boston Medical Center researchers found that only a small number of those who test positive for those infections at a drug detoxification ...
Sep 3, 2020
0
21
The observational study involving more than 1,300 people was led by the London School of Hygiene & Tropical Medicine (LSHTM), University of Malawi College of Medicine and colleagues at the University of Cambridge.
Sep 2, 2020
0
4
Scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection from the infection with fewer side effects. The drug, which was tested in ...
Aug 21, 2020
1
293
Heavy use of class A drugs, such as heroin, methamphetamine, or cocaine is linked to a heightened risk of partial or total blindness among US military personnel, finds research published online in the journal BMJ Military ...
Aug 13, 2020
0
2
An immunomodulatory drug called fingolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune cells, according to a study published ...
Aug 13, 2020
0
47
